Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Oral Suspension safely and effectively. See full prescribing information for Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Oral Suspension. Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, for oral administration, CII Initial U.S. Approval: 1987
Medication labelWhy this: Advisory · dailymed-prescription
Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension is indicated for the temporary relief of cough and upper respiratory symptoms associated with allergy or the common cold in patients 18 years of age and older. Important Limitations of Use: • Not indicated for pediatric patients under 18 years of age [see Use in Specific Populations (8.4 ) ]. • Contraindicated in pediatric patients less than 6 years of age [see Contraindications (4) ]. • Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see Warnings and Precautions (5.1) ], reserve Hydrocodone Polistirex and Chlorpheniramine Polistirex for use in adult patients for whomthe benefits of cough suppression are expected to outweigh the risks, and in whom an adequateassessment of the etiology of the cough has been made.
- generic_name
- hydrocodone polistirex and chlorpheniramine polistirex
- product_names
- Hydrocodone Polistirex and Chlorpheniramine Polistirex
- ndc
- 63629-2303, 27808-086, 63629-2303-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en